Results 81 to 90 of about 37,023 (237)
Update on the management of chemotherapy-induced nausea and vomiting – focus on palonosetron
Michelle Zhou, Marko Popovic, Mark Pasetka, Natalie Pulenzas, Soha Ahrari, Edward Chow, Carlo DeAngelis Department of Pharmacy, Odette Cancer Center, Sunnybrook Health Sciences Center, University of Toronto, Toronto, ON, Canada Purpose: Nausea and
Zhou M +6 more
core
Objectives Pulmonary carcinoma in dogs is commonly managed with surgical resection; however, the role of adjuvant chemotherapy for grade II and III carcinomas remains unclear. This retrospective multicentre study investigated the outcomes in dogs treated with vinorelbine‐based adjuvant treatment (as monotherapy or combined chemotherapy) following ...
N. Wong, L. Brockley, S. Rajan, J. Yu
wiley +1 more source
Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron [PDF]
Vito Lorusso National Cancer Research Centre, Istituto Tumori Giovanni Paolo II, Bari, Italy Abstract: As recommended by most recent antiemetic guidelines, the optimal prophylaxis of chemotherapy-induced nausea and vomiting (CINV) requires the ...
Lorusso V
core
Doxorubicin‐induced Cardiotoxicity in Dogs: A Narrative Review
ABSTRACT Doxorubicin, an anthracycline widely used in both human and veterinary oncology, is highly effective against a variety of malignancies in dogs, including lymphomas, sarcomas and carcinomas. Despite its efficacy, doxorubicin exposure can be associated with cardiotoxicity, which may present acutely or chronically, potentially leading to severe ...
Supita Sunpongsri +4 more
wiley +1 more source
Risk factors, management and prevention of Chemotherapy-Induced Nausea and Vomiting: scoping review
OBJECTIVE To identify and synthesize scientific evidence on risk factors, management and prevention of inappetence, nausea and vomiting induced by outpatient anticancer therapy. QUESTION FORMULATION P (Population) – Patients on antineoplastic therapy. C (
Patrícia Peres de Oliveira
core +1 more source
ABSTRACT Introduction BTK inhibitors have transformed the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), but strategies to deepen and prolong response are needed. Lenalidomide is active in CLL/SLL through a non‐overlapping mechanism but is limited by toxicity.
Steven M. Bair +11 more
wiley +1 more source
Omission of dexamethasone in prophylaxis for highly emetogenic chemotherapy in patients with breast cancer [PDF]
Objective Chemotherapy-induced nausea and vomiting are highly prevalent adverse events that can lead to poor treatment adherence and a decreased quality of life.
Camilla Vieira de Rebouças +4 more
doaj +1 more source
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy
Rudolph M NavariIndiana University School of Medicine South Bend, South Bend, IN USAAbstract: Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life.
Rudolph M Navari
core
The Microbiome in Cancer: Composition, Mechanisms, and Therapeutic Implications
1. This paper proposes the “oncobiome” as a unifying conceptual framework that integrates commensal, pathobiont, and tumor‐resident microbes into a coherent biological processor driving malignancy. 2. This study describes the dynamic shift from a homeostatic microbiome to a pathological oncobiome, detailing how diet, antibiotics, and environment ...
Xuan Zhang +6 more
wiley +1 more source
ObjectiveTo systematically evaluate the clinical effect of neiguan acupoint pressure on improving chemotherapy-induced nausea and vomiting in cancer patients.MethodThe RCTs related to effect of neiguan acupoint pressure on improving chemotherapy-induced ...
CHEN Feng +4 more
doaj

